| 1 |
Meyer JC, Macbride-stewart S, Fadare JO, Abdulrahman Jairoun A, Haque M, Massele A, Kumar S, Sefah IA, P Skosana P, Godman B. Key Considerations From a Health Authority Perspective When Proton Pump Inhibitors Are Used to Treat Gastroesophageal Reflux Disease (GERD) and Their Implications. Cureus 2022. [DOI: 10.7759/cureus.31918] [Reference Citation Analysis]
|
| 2 |
Pawłowska I, Kuźbicka K, Krzyżaniak N, Kocić I. Interactions between selected over-the-counter drugs and food: clinical relevance and prevention. Int J Food Sci Nutr 2022;:1-14. [PMID: 36068659 DOI: 10.1080/09637486.2022.2119214] [Reference Citation Analysis]
|
| 3 |
Tarabay RB, Osman MH, Aridi RS, Hlais SA, Beshara RY, Lakkis NA. The effect of a patient informative leaflet on chronic use of proton pump inhibitors in a primary care center: a randomized control trial. Hosp Pract (1995) 2022;:1-8. [PMID: 35993151 DOI: 10.1080/21548331.2022.2114743] [Reference Citation Analysis]
|
| 4 |
Hussain S, Singh A, Antony B, Klugarová J, Murad MH, Jayraj AS, Langaufová A, Klugar M. Proton Pump Inhibitors Use and Risk of Preeclampsia: A Meta-Analysis. JCM 2022;11:4675. [DOI: 10.3390/jcm11164675] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 5 |
Ben Ghezala I, Luu M, Bardou M. An update on drug-drug interactions associated with proton pump inhibitors. Expert Opin Drug Metab Toxicol 2022. [PMID: 35787720 DOI: 10.1080/17425255.2022.2098107] [Reference Citation Analysis]
|
| 6 |
Liu Y, Chen M. Clostridioides difficile Infection in Liver Cirrhosis: A Concise Review. Can J Gastroenterol Hepatol 2022;2022:4209442. [PMID: 35711246 DOI: 10.1155/2022/4209442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Hussain S, Singh A, Antony B, Klugarová J, Klugar M. Proton pump inhibitors use and risk of preeclampsia.. [DOI: 10.1101/2021.09.15.21263602] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 8 |
Rosenberg V, Tzadok R, Chodick G, Kariv R. Proton pump inhibitors long term use-trends and patterns over 15 years of a large health maintenance organization. Pharmacoepidemiol Drug Saf 2021;30:1576-87. [PMID: 34453456 DOI: 10.1002/pds.5352] [Reference Citation Analysis]
|
| 9 |
Patel D, Bertz R, Ren S, Boulton DW, Någård M. A Systematic Review of Gastric Acid-Reducing Agent-Mediated Drug-Drug Interactions with Orally Administered Medications. Clin Pharmacokinet 2020;59:447-62. [PMID: 31788764 DOI: 10.1007/s40262-019-00844-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 15.5] [Reference Citation Analysis]
|
| 10 |
Uchiyama AAT, Silva PAIA, Lopes MSM, Yen CT, Ricardo ED, Mutão T, Pimenta JR, Machado LM, Shimba DS, Peixoto RD. Proton Pump Inhibitors and Oncologic Treatment Efficacy: A Practical Review of the Literature for Oncologists. Curr Oncol 2021;28:783-99. [PMID: 33546228 DOI: 10.3390/curroncol28010076] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 11 |
Kim J, Nimeri A, Khorgami Z, El Chaar M, Lima AG, Vosburg RW. Metabolic bone changes after bariatric surgery: 2020 update, American Society for Metabolic and Bariatric Surgery Clinical Issues Committee position statement. Surgery for Obesity and Related Diseases 2021;17:1-8. [DOI: 10.1016/j.soard.2020.09.031] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 12 |
Chen G, Ning LJ, Qin Y, Zhao B, Mei D, Li XM. Acute kidney injury following the use of different proton pump inhibitor regimens: A real-world analysis of post-marketing surveillance data. J Gastroenterol Hepatol 2021;36:156-62. [PMID: 32542684 DOI: 10.1111/jgh.15151] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 13 |
Jain M. Feasibility and determinants of deprescription of proton pump inhibitors in patients with typical reflux symptoms. Gastroenterol Hepatol Endosc Pract 2021;1:98. [DOI: 10.4103/ghep.ghep_25_20] [Reference Citation Analysis]
|
| 14 |
Rieder E. Anti-Reflux Surgery III: Endoscopic Fundoplications. Multidisciplinary Management of Gastroesophageal Reflux Disease 2021. [DOI: 10.1007/978-3-030-53751-7_9] [Reference Citation Analysis]
|
| 15 |
Dharmarajan TS. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing. J Am Med Dir Assoc 2021;22:15-22. [PMID: 33321078 DOI: 10.1016/j.jamda.2020.09.046] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 16 |
Singh-Franco D, Mastropietro DR, Metzner M, Dressler MD, Fares A, Johnson M, De La Rosa D, Wolowich WR. Impact of pharmacy-supported interventions on proportion of patients receiving non-indicated acid suppressive therapy upon discharge: A systematic review and meta-analysis. PLoS One 2020;15:e0243134. [PMID: 33270710 DOI: 10.1371/journal.pone.0243134] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Whetsel T, Garofoli G. Chapter 13: Heartburn and Dyspepsia. Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care, 20th Edition 2020. [DOI: 10.21019/9781582123172.ch13] [Reference Citation Analysis]
|
| 18 |
Aleraij S, Alhowti S, Ferwana M, Abdulmajeed I. Effect of proton pump inhibitors on bone mineral density: A systematic review and meta-analysis of observational studies. Bone Rep 2020;13:100732. [PMID: 33299906 DOI: 10.1016/j.bonr.2020.100732] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 19 |
Huang YT, Chen CS, Chen HA, Hsu HS, Liang MH, Chang MH, Liao CH. Klebsiella pneumoniae bacteremia revisited: Comparison between 2007 and 2017 prospective cohorts at a medical center in Taiwan. J Infect 2020;81:753-7. [PMID: 32860818 DOI: 10.1016/j.jinf.2020.08.039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Taneja G, Thanikachalam PV, Rajput SK. Dose and time-dependent toxicological impact of pantoprazole on vascular endothelium and renal tissue. Toxicol Lett 2020;333:97-104. [PMID: 32763312 DOI: 10.1016/j.toxlet.2020.07.031] [Reference Citation Analysis]
|
| 21 |
Scarpignato C, Tolone S. Addressing long-term PPI safety. Dig Liver Dis 2020;52:853-6. [PMID: 32601032 DOI: 10.1016/j.dld.2020.05.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 22 |
Babic A, Zhang X, Morales-Oyarvide V, Yuan C, Khalaf N, Khalili H, Lochhead P, Chan AT, Ogino S, Wolpin BM, Wu K, Fuchs CS, Giovannucci EL, Stampfer MJ, Ng K. Acid-suppressive medications and risk of colorectal cancer: results from three large prospective cohort studies. Br J Cancer 2020;123:844-51. [PMID: 32541871 DOI: 10.1038/s41416-020-0939-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 23 |
Ayazi S, Zheng P, Zaidi AH, Chovanec K, Chowdhury N, Salvitti M, Komatsu Y, Omstead AN, Hoppo T, Jobe BA. Magnetic Sphincter Augmentation and Postoperative Dysphagia: Characterization, Clinical Risk Factors, and Management. J Gastrointest Surg 2020;24:39-49. [PMID: 31388888 DOI: 10.1007/s11605-019-04331-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 24 |
Manolis AA, Manolis TA, Melita H, Katsiki N, Manolis AS. Proton pump inhibitors and cardiovascular adverse effects: Real or surreal worries? Eur J Intern Med 2020;72:15-26. [PMID: 31796246 DOI: 10.1016/j.ejim.2019.11.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 25 |
Lenoir C, El Biali M, Luthy C, Grosgurin O, Desmeules JA, Rollason V. Snapshot of proton pump inhibitors prescriptions in a tertiary care hospital in Switzerland: less is more? Int J Clin Pharm 2019;41:1634-41. [DOI: 10.1007/s11096-019-00929-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 26 |
Rogers BD, Gyawali CP. Why differences between New York and New Delhi matter in approach to gastroesophageal reflux disease. Indian J Gastroenterol 2019;38:371-7. [PMID: 31768894 DOI: 10.1007/s12664-019-00987-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 27 |
Bhatia SJ, Makharia GK, Abraham P, Bhat N, Kumar A, Reddy DN, Ghoshal UC, Ahuja V, Rao GV, Devadas K, Dutta AK, Jain A, Kedia S, Dama R, Kalapala R, Alvares JF, Dadhich S, Dixit VK, Goenka MK, Goswami BD, Issar SK, Leelakrishnan V, Mallath MK, Mathew P, Mathew P, Nandwani S, Pai CG, Peter L, Prasad AVS, Singh D, Sodhi JS, Sud R, Venkataraman J, Midha V, Bapaye A, Dutta U, Jain AK, Kochhar R, Puri AS, Singh SP, Shimpi L, Sood A, Wadhwa RT. Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology. Indian J Gastroenterol 2019;38:411-40. [PMID: 31802441 DOI: 10.1007/s12664-019-00979-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 28 |
Wiens E, Kovaltchouk U, Koomson A, Targownik LE. The Clinician's Guide to Proton-Pump Inhibitor Discontinuation. J Clin Gastroenterol 2019;53:553-9. [PMID: 31356559 DOI: 10.1097/MCG.0000000000001243] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 29 |
Jordakieva G, Kundi M, Untersmayr E, Pali-Schöll I, Reichardt B, Jensen-Jarolim E. Country-wide medical records infer increased allergy risk of gastric acid inhibition. Nat Commun 2019;10:3298. [PMID: 31363098 DOI: 10.1038/s41467-019-10914-6] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 30 |
Claßen M, Schmidt-choudhury A. Ernährungsprobleme und Unterernährung bei schwer neurologisch beeinträchtigten Kindern und Jugendlichen. Monatsschr Kinderheilkd 2019;167:675-85. [DOI: 10.1007/s00112-019-0726-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 31 |
Makowsky M. Heartburn. Patient Assessment in Clinical Pharmacy 2019. [DOI: 10.1007/978-3-030-11775-7_9] [Reference Citation Analysis]
|
| 32 |
Guadagnoli LA, Pandolfino JE, Yadlapati R. Functional Swallowing Disorders. Gastrointestinal and Liver Disorders in Women’s Health 2019. [DOI: 10.1007/978-3-030-25626-5_2] [Reference Citation Analysis]
|
| 33 |
Yadlapati R, Khan A. Gastroesophageal Reflux Disease. Gastrointestinal and Liver Disorders in Women’s Health 2019. [DOI: 10.1007/978-3-030-25626-5_3] [Reference Citation Analysis]
|
| 34 |
Masoodi I. Prescription pattern of proton pump inhibitors among adults: A drug utilization study in the western region of Saudi Arabia. IJMDC 2019. [DOI: 10.24911/ijmdc.51-1552663163] [Reference Citation Analysis]
|
| 35 |
Cohen SM, Lee HJ, Leiman DA, Roy N, Misono S. Associations between Community-Acquired Pneumonia and Proton Pump Inhibitors in the Laryngeal/Voice-Disordered Population. Otolaryngol Head Neck Surg 2019;160:519-25. [PMID: 30419774 DOI: 10.1177/0194599818811292] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 36 |
Bajaj JS, Acharya C, Fagan A, White MB, Gavis E, Heuman DM, Hylemon PB, Fuchs M, Puri P, Schubert ML, Sanyal AJ, Sterling RK, Stravitz TR, Siddiqui MS, Luketic V, Lee H, Sikaroodi M, Gillevet PM. Proton Pump Inhibitor Initiation and Withdrawal affects Gut Microbiota and Readmission Risk in Cirrhosis. Am J Gastroenterol 2018;113:1177-86. [PMID: 29872220 DOI: 10.1038/s41395-018-0085-9] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 14.6] [Reference Citation Analysis]
|
| 37 |
Haastrup PF, Thompson W, Søndergaard J, Jarbøl DE. Side Effects of Long-Term Proton Pump Inhibitor Use: A Review. Basic Clin Pharmacol Toxicol 2018;123:114-21. [PMID: 29658189 DOI: 10.1111/bcpt.13023] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 11.8] [Reference Citation Analysis]
|
| 38 |
Rieder E, Riegler M, Simić AP, Skrobić OM, Bonavina L, Gurski R, Paireder M, Castell DO, Schoppmann SF. Alternative therapies for GERD: a way to personalized antireflux surgery. Ann N Y Acad Sci 2018;1434:360-9. [PMID: 29774563 DOI: 10.1111/nyas.13851] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 39 |
Shizuma T. Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review. World J Hepatol 2018;10:254-66. [PMID: 29527261 DOI: 10.4254/wjh.v10.i2.254] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 40 |
Yang X, Li Y, Sun Y, Zhang M, Guo C, Mirza IA, Li YQ. Vonoprazan: A Novel and Potent Alternative in the Treatment of Acid-Related Diseases. Dig Dis Sci 2018;63:302-11. [PMID: 29282636 DOI: 10.1007/s10620-017-4866-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 41 |
Mohamed Ibrahim OH, Rashrash MEA, Albasha R, Alani R, Khadhum S, Soliman S. Evaluation of Appropriateness of Proton Pump Inhibitors (PPIs) Use in the Region of Sharjah, United Arab Emirates (UAE). PP 2018;09:149-156. [DOI: 10.4236/pp.2018.96012] [Reference Citation Analysis]
|
| 42 |
Gyawali CP, Fass R. Management of Gastroesophageal Reflux Disease. Gastroenterology 2018;154:302-18. [PMID: 28827081 DOI: 10.1053/j.gastro.2017.07.049] [Cited by in Crossref: 164] [Cited by in F6Publishing: 165] [Article Influence: 32.8] [Reference Citation Analysis]
|
| 43 |
Shiraev TP, Bullen A. Proton Pump Inhibitors and Cardiovascular Events: A Systematic Review. Heart Lung Circ 2018;27:443-50. [PMID: 29233498 DOI: 10.1016/j.hlc.2017.10.020] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
|
